TMCx Accelerator

VC Fund

Houston, United States

Find emails

Save

TMCx Accelerator is a VC fund in Houston focused on Health Care and Medical. The Texas Medical Center accelerator (TMCx) provides a gateway to the facilities, resources and network of the world’s largest medical center. TMCx resources for startups include: unprecedented clinical access, an all-star network of advisors, and newly renovated office space. From ideation to commercialization, they work closely with life scienceand digital health startups to transform scientific innovations into tangible tools that save lives, manage disease, and improve quality of life.

Total investments:: 19
Last investment:: Dec 2015
Lead investor:: 0%

Last updated: Aug 2026

For AI agents: llms.txt

Industries TMCx Accelerator invests in

Health CareMedicalMedical DeviceBiotechnologyInformation Technology

Stages TMCx Accelerator invests in

SeedGrantSeries AFunding RoundConvertible Note

Countries TMCx Accelerator invests in

United StatesGermany

Investment Focus

Industry

Health Care 14 (74%)
Medical 7 (37%)
Medical Device 6 (32%)
Biotechnology 5 (26%)
Information Technology 5 (26%)

See all 32 industries →

Stage

Seed 15 (79%)
Grant 1 (5%)
Series A 1 (5%)
Funding Round 1 (5%)
Convertible Note 1 (5%)

Country

United States 18 (95%)
Germany 1 (5%)

Investments

Company	Description	Round
Zerigo Health	Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions.Clarify Medicalindicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.	$1.4M / Series A / Dec 03, 2015
Adient Medical	Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.	$500K / Seed / Sep 01, 2015
Delafield Solutions	Delafield’s Hydrogen Peroxide Systems provide continuous microbial control in occupied spaces. This unique technology produces dilute Hydrogen Peroxide in pure gas form which attacks the viruses, bacteria, and molds that commonly cause illnesses ranging from the flu to deadly hospital-acquired infections. The concentration is well below OSHA limitsallowing the area to remain in use while our technology offers protection from germs on a sustained basis.This capability is revolutionary, providing the ability to continuously reduce microbial loads and also prevent mold infestations. Like air, our patented systems permeate the entire enclosed space and reaches every surface – even those surfaces rarely cleaned by conventional methods. This means soft surfaces like curtains or seat pockets and hard surfaces like work-out equipment will be treated as well as the more typical surfaces like desks and tables.	Seed / Mar 09, 2015
Noninvasix	Noninvasix, Inc. (the “Company” or “Noninvasix”) is a medical technology company that has developed a novel solution to non-invasively monitor for the first time, oxygen sufficiency in organs and veins. The Company was founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch (UTMB) and is based out ofHouston, Texas. The Company has raised over $4.8 million to date including an oversubscribed $2 million seed round in Q2 2020. The platform technology of the Company has been developed with $6 million in grants from the NIH and DOD. The Company has also been a part of prestigious accelerator programs such as Philips Healthworks, TMCx, JLabs, Health Wildcatters and has won multiple awards for their innovation. The non-invasive technology has been clinically validated in multiple peer-reviewed journals. FDA pre-submission has been completed and the FDA has agreed for a De-novo clearance pathway. The IP portfolio of the Company includes 30 worldwide patents and 10 U.S. patents.	Convertible Note / Mar 09, 2015
Creative Bioinformatics, LLC	Creative Bioinformatics Consultants, LLC is a computational bioinformatics contract research organization delivering customized software and data analysis for all types of biomedical research projects. Clients include academic laboratories, non-profit research organizations, and biotechnology companies looking to leverage the power ofcomputational approaches to data analysis at rates that are more cost efficient than hiring and training expert bioinformaticans in-house. Our bioinformaticians have expertise in gene expression analysis (microarray and RNAseq), DNA sequencing analysis, protein bioinformatics, machine learning, network analysis, computational chemistry, software development, and many other bioinformatic techniques. We also provide bioinformatics training resources. We will work one-on-one with your organization to address your specific project's needs. Think of us as your personalized bioinformatics team for one specific project or a series of ongoing projects.	Seed / Mar 09, 2015
Clear Ear	Clear Ear Inc. is a privately held medical device company focused on delivering hearing innovations that make ears around the world happier. Clear Ear was founded out of the Stanford Biodesign Program in 2011. Its first product line is TEC (Total Ear Care), whose initial application addresses the number one cause of hearing loss and hearing-aidfailure worldwide--cerumen (a.k.a. ear wax) impaction. This solution seeks to expand patient access and improve quality of ear care for the 47M Americans and over 350M patients affected worldwide.	Seed / Mar 09, 2015
Laser Tissue Welding	Laser Tissue Welding, Inc. is a privately owned biotherapeutic company located in Humble Texas, incorporated in Delaware in 2004. It is structured as a vertically integrated research, development, and manufacturing entity. At present the company focuses its research and product development on two patented and proprietary platforms:Point, aimand fuse: Innovative laser mediated instant hemostasis and sutureless surgical repair using human albumin based bio-absorbable biomaterials to join, repair and instantly stopping bleeding on any tissue surface even in the presence of coagulation failure or therapeutic anticoagulation.Transparent bio-absorbable human albumin burns and chronic wound dressings that can be customized with growth factors and antibiotics.	Seed / Mar 09, 2015
Sage Health	Sage Health offers a web-based platform for hospitals and other caregivers to digitize and automate admission, discharge, and care delivery processes.	Seed / Mar 09, 2015
Admetsys	Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose. The system has undergone 3 successful FDA-approved clinical trials with 97% control between 80–125 mg/dl and zero incidents of low blood sugar.	Grant / Mar 09, 2015
Proximare Health	At Proximare their sole focus is on enabling a more effective and efficient referral process. They are fortunate that many organizations have trusted us to process millions of referrals on their behalf over the last decade and with that experience they have and will continue to make enhancements to solidify their position as the only rules basedfull cycle referral management platform on the market.Proximare's core product IRIS (Internet Referral Information System) is a web-based patient referral system that incorporates powerful in-line rule technology. Clients use sample rule sets provided by Proximare to tailor their own rules, which IRIS incorporates into daily workflow.	Seed / Mar 09, 2015
See all 19 investments →

Co-Investors

AngelMD 1 deal together

Cherry Ventures 1 deal together

CH Innovations 1 deal together

Health Wildcatters 1 deal together

Houston Angel Network 1 deal together

Texas HALO Fund 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Similar Investors

Recommended lists

SaaS Investors 99,274 investors Enterprise Investors 77,348 investors Health Care Investors 43,014 investors Biotech Investors 21,775 investors Biotechnology Investors 19,370 investors Medical Investors 18,848 investors Medical Device Investors 11,047 investors SaaS VC Funds 61,208 investors Enterprise VC Funds 49,693 investors

FAQ

What does TMCx Accelerator invest in?

TMCx Accelerator invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Grant stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did TMCx Accelerator last invest?

The most recent investment recorded for TMCx Accelerator closed in Dec 2015. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.